Determining The Scope Of FCA's Public Disclosure Bar
Law360, New York (February 18, 2016, 11:28 AM EST) -- Michael A. Schwartz
Kate A. Stanley
Pharmaceutical, health care and government contracting companies that have faced federal False Claims Act lawsuits know that they can be high risk, high exposure and high anxiety. Indeed, FCA cases can involve years of costly litigation and the threat of potentially severe penalties.
One avenue of early defense is to invoke the so-called “public disclosure bar,” which prevents a person from pursuing an action based on certain publicly disclosed information unless that person qualifies as an “original source” of the information. After all, the purpose of the FCA is to expose allegedly hidden fraud, not...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!